Filing Details
- Accession Number:
- 0001209191-23-047348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-25 16:45:44
- Reporting Period:
- 2023-08-24
- Accepted Time:
- 2023-08-25 16:45:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1511365 | P Pamela Palmer | C/O Acelrx Pharmaceuticals, Inc. 1850 Gateway Drive, Suite 175 San Mateo CA 94404 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-08-24 | 9,514 | $1.17 | 38,195 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-25 | 7,442 | $1.09 | 30,753 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.17 to $1.19 on August 24, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares sold at each separate price.
- Balance includes non-reportable acquisition of 4,394 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023.
Billionaire Hedge Funds
